News & Updates
Research, news, and myth-busting on peptides, SARMs, and the compounds our community actually searches for.
Does Cycle Syncing Actually Work? What the Evidence Does (and Doesn't) Show
The hormonal swings behind cycle syncing are real. The specific what-to-eat-each-week protocol isn't validated — a board-certified reproductive endocrinologist says the research on cycle syncing itself basically doesn't exist yet.
What the FDA's Compounding Review Means for BPC-157
BPC-157 just went in front of the FDA's compounding review board. Here's what Category 2 restriction actually means — and doesn't — for access.
BPC-157's Human Evidence Gap: What the Research Actually Shows
Zero human clinical trials, one small safety pilot, and 35 rat studies: what "100+ studies on BPC-157" really means before you trust the claim.
GHK-Cu Is Trending Fast — Here's What the Actual Science Says
GHK-Cu (copper peptide) searches are up over 1,000% this year. One real human trial backs the hype — here's exactly what it found.
The February Peptide Reclassification Almost No One Covered
HHS quietly moved 14 of 19 restricted peptides further out of reach in February 2026 — the reclassification almost no peptide community covered.
If You Compete in Tested Sport, Know These Peptides Are Banned Outright
BPC-157, TB-500, and CJC-1295 are all WADA-prohibited outright — and a positive drug test isn't even required to trigger a ban.
What the Enhanced Games Actually Proved (and Didn't)
40 athletes competed openly enhanced at the 2026 Enhanced Games in Las Vegas. What the event actually proved about medically-supervised enhancement — and what it didn't.
The Retatrutide-Cagrilintide Stack Hype Is Ahead of the Data
Everyone's talking about stacking Retatrutide with Cagrilintide — but no published trial has ever tested that exact combination. Here's the closest real data.
Need something specific, or placing a wholesale order? Message us on Telegram — fastest way to reach us.